KTTA stock

Analyzing Pasithea Therapeutics Corp (KTTA) After Recent Trading Activity
Daniel Torres
Pasithea Therapeutics Corp’s recent filing unveils that its Director STEINMAN LAWRENCE acquired Company’s shares for reported $100000.0 on Nov 28 ...





